The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight
Ji-Young Cho, Tae-Heum Chung, Kyoung-Mo Lim, Hee-Jin Park, Jung-Mi Jang
Korean J Fam Med. 2014;35(5):243-250.   Published online 2014 Sep 24     DOI:
Citations to this article as recorded by Crossref logo
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Tang, Cheng Han Ng, Poh Hui Phang, Kai En Chan, Yip Han Chin, Clarissa Elysia Fu, Rebecca Wenling Zeng, Jieling Xiao, Darren Jun Hao Tan, Jingxuan Quek, Wen Hui Lim, Lung Yi Mak, Jiong-wei Wang, Nicholas W.S. Chew, Nicholas Syn, Daniel Q. Huang, Moh
Clinical Gastroenterology and Hepatology.2023; 21(7): 1750.     CrossRef
Possibilities of improving the effectiveness of treatment of manifestations of metabolic syndrome in the elderly (on the example of taurine)
E. V. Golovanova
Experimental and Clinical Gastroenterology.2023; (8): 171.     CrossRef
The Effect of Sira Vedha (Phlebotomy) at Right Elbow Joint in the Management of Non-alcoholic Fatty Liver Disease - Randomized Controlled Clinical Trial
Gaurav Sawarkar, Priti Desai, Punam Sawarkar
Journal of Natural Remedies.2023; : 879.     CrossRef
Joint effect of changes in physical activity and weight on incident non-alcoholic fatty liver disease
Yi-Lin Tsai, Sean Chun-Chang Chen
Journal of Epidemiology and Community Health.2021; 75(12): 1215.     CrossRef
Natural history of NASH and HCC
Francesco Negro
Liver International.2020; 40(S1): 72.     CrossRef
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher Donald Stave, Tetsuya Hosaka, Ramsey C Cheung, Mindie H Nguyen
The Lancet Gastroenterology & Hepatology.2020; 5(8): 739.     CrossRef
Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin
BMJ Open Gastroenterology.2019; 6(1): e000307.     CrossRef
Non-viral liver diseases: pathogenetic approaches to therapy
M. A. Osadchuk, E. D. Mironova
Medical alphabet.2019; 3(20): 30.     CrossRef
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Shiv Chitturi, Yogesh Chawla, Yock Young Dan, Ajay Duseja, Jiangao Fan, Khean‐Lee Goh, Masahide Hamaguchi, Etsuko Hashimoto, Seung Up Kim, Laurentius Adrianto Lesmana, Yu‐Cheng Lin, Chun‐Jen Liu, Yen‐Hsuan Ni, Jose S
Journal of Gastroenterology and Hepatology.2018; 33(1): 70.     CrossRef
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict, Xuchen Zhang
World Journal of Hepatology.2017; 9(16): 715.     CrossRef
Application of Computer-Aided Diagnosis for the Differential Diagnosis of Fatty Liver in Computed Tomography Image
Hyong-Hu Park, Jin-Soo Lee
Journal of the Korean Society of Radiology.2016; 10(6): 443.     CrossRef
Role of diet on non-alcoholic fatty liver disease: An updated narrative review
Dimitrios Papandreou
World Journal of Hepatology.2015; 7(3): 575.     CrossRef
Health Benefits of Long-Term Weight-Loss Maintenance
Christian F. Rueda-Clausen, Ayodele A. Ogunleye, Arya M. Sharma
Annual Review of Nutrition.2015; 35(1): 475.     CrossRef